tiprankstipranks
AEON Biopharma (AEON)
XASE:AEON
US Market
Want to see AEON full AI Analyst Report?

AEON Biopharma (AEON) Income Statement

224 Followers

AEON Biopharma Income Statement

Last quarter (Q1 2026), AEON Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, AEON Biopharma's net income was $-11.79M. See AEON Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 12.80M$ -72.98M$ 348.09M$ 48.43M$ 65.85M
Depreciation and Amortization
$ 78.00K$ 97.00K$ 99.00K$ 68.00K$ 3.00K
EBITDA
$ -16.22M$ -27.73M$ -52.74M$ -48.36M$ -36.88M
Operating Income
$ -12.80M$ 72.98M$ -348.09M$ -48.43M$ -65.85M
Other Income/Expenses
$ -26.42M$ -30.98M$ -36.55M$ -4.13M$ 10.21M
Pretax Income
$ -39.22M$ 42.01M$ -384.63M$ -52.56M$ -55.64M
Net Income
$ -39.22M$ 42.01M$ -384.63M$ -52.56M$ -55.64M
Per Share Metrics
Basic EPS
$ -3.95$ 77.74$ -4.99$ -27.25$ -31.73
Diluted EPS
$ -3.95$ 72.93$ -4.99$ -27.25$ -31.73
Weighted Average Shares Outstanding
9.92M 575.00K 77.07M 1.93M 1.75M
Weighted Average Shares Outstanding (Diluted)
9.92M 575.95K 77.07M 1.93M 1.75M
Currency in USD

AEON Biopharma Earnings and Revenue History